SCHEMBL29770528

SCHEMBL29770528

COc1ccc(C(OC[C@@](CO)(CO[Si](C(C)C)(C(C)C)C(C)C)O[C@H](CO)n2cnc3c(NC(=O)c4ccccc4)ncnc32)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK5 Q00535 3/20 0.37
▸ CDK5R1 Q15078 3/20 0.37
▸ CCNB2 O95067 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ CCNB3 Q8WWL7 1/20 0.36
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ TMIGD3 P0DMS9 2/20 0.33
▸ ADORA3 P0DMS8 2/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ ERBB3 P21860 1/20 0.33
▸ TYMP P19971 1/20 0.32
▸ CCNE2 O96020 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ TDP2 O95551 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23243951 1.00 CDK5 (0.37) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL23243953 1.00 CDK5 (0.37) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL23243917 0.89 CDK5 (0.32) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL29770553 0.89 CDK5 (0.32) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL23243915 0.89 CDK5 (0.32) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL31314694 0.83 CDK5 (0.37) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL38651357 0.82 HDAC1 (0.39) CDK5CDK5R1CCNB2CDK1CCNB1
SCHEMBL23069400 0.82 TYMP (0.36) CDK5CDK5R1TYMPCCNE2CCNE1
SCHEMBL23069401 0.82 TYMP (0.36) CDK5CDK5R1TYMPCCNE2CCNE1
SCHEMBL19221725 0.81 CCNB2 (0.38) CDK5CDK5R1CCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112105625-B Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same 赛诺菲 2024-12-31 — — CN disclosed
US-20220372063-A1 OLIGONUCLEOTIDES CONTAINING NUCLEOTIDE ANALOGS SANOFI (FR) 2022-11-24 — — US disclosed
EP-4025582-A1 OLIGONUCLEOTIDES CONTAINING NUCLEOTIDE ANALOGS SANOFI (FR) 2022-07-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220372063-A1 OLIGONUCLEOTIDES CONTAINING NUCLEOTIDE ANALOGS DCLRE1B, UPF1, IGF2BP1 CDK5 2978/4885CDK5R1 2176/4885CCNB2 1964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback